Imunon reports 2024 EPS ($1.62) vs. ($2.16) last year
PremiumThe FlyImunon reports 2024 EPS ($1.62) vs. ($2.16) last year
1M ago
Imunon announces new analyses of results from Phase 1 trial of IMNN-101
Premium
The Fly
Imunon announces new analyses of results from Phase 1 trial of IMNN-101
1M ago
IMNN Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
IMNN Upcoming Earnings Report: What to Expect?
1M ago
Imunon announces additional data from results from Phase 2 OVATION 2 study
PremiumThe FlyImunon announces additional data from results from Phase 2 OVATION 2 study
4M ago
Imunon announces results from End-of-Phase 2 meeting with FDA for IMNN-001
Premium
The Fly
Imunon announces results from End-of-Phase 2 meeting with FDA for IMNN-001
4M ago
Imunon, Inc. Reports Q3 2024 Earnings and Progress
Premium
Company Announcements
Imunon, Inc. Reports Q3 2024 Earnings and Progress
5M ago
Imunon to present Phase 2 data of IMNN-001
PremiumThe FlyImunon to present Phase 2 data of IMNN-001
5M ago
Imunon reports inducement grant under NASDAQ listing rule
Premium
The Fly
Imunon reports inducement grant under NASDAQ listing rule
6M ago
Imunon Welcomes Susan Eylward as General Counsel, Strengthens Leadership Team
Premium
Company Announcements
Imunon Welcomes Susan Eylward as General Counsel, Strengthens Leadership Team
6M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100